Storia in 20 fonti

A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting chance

The US FDA has approved Revolution Medicines' pancreatic cancer drug Rasonque. This once-daily pill doubles survival for patients with advanced metastatic pancreatic cancer. Rasonque blocks the RAS protein, which drives tumor growth in many pancreatic cancers. Doctors hail this development as a significant breakthrough in cancer treatment. The drug is now available in the US, offering hope to many suffering patients.

Raccontata da

nbcnews.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo14 h fa

A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting…

originale

Timeline cronologica

mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.
mercoledì 26 agosto 2026·biopharmadive.com
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly…

A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting chance

Confronto fonti

A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting…

Timeline cronologica

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

FDA approves new drug Rasonque to treat advanced pancreatic cancer

FDA approves pancreatic cancer drug that nearly doubles survival time

Rasonque gets US nod: The pill that nearly doubles pancreatic cancer survival — and is set to $475,000 a year

FDA approves ‘game-changing’ pancreatic cancer drug

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet | Fortune

FDA approves new pancreatic cancer drug that could extend patients' lives

FDA approves new drug Rasonque to treat advanced pancreatic cancer